1. Home
  2. ACRV vs NWTN Comparison

ACRV vs NWTN Comparison

Compare ACRV & NWTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • NWTN
  • Stock Information
  • Founded
  • ACRV 2018
  • NWTN 2016
  • Country
  • ACRV United States
  • NWTN United Arab Emirates
  • Employees
  • ACRV N/A
  • NWTN N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • NWTN Auto Manufacturing
  • Sector
  • ACRV Health Care
  • NWTN Consumer Discretionary
  • Exchange
  • ACRV Nasdaq
  • NWTN Nasdaq
  • Market Cap
  • ACRV 225.8M
  • NWTN 194.7M
  • IPO Year
  • ACRV 2022
  • NWTN N/A
  • Fundamental
  • Price
  • ACRV $7.87
  • NWTN $0.62
  • Analyst Decision
  • ACRV Strong Buy
  • NWTN
  • Analyst Count
  • ACRV 5
  • NWTN 0
  • Target Price
  • ACRV $22.60
  • NWTN N/A
  • AVG Volume (30 Days)
  • ACRV 103.0K
  • NWTN 18.8K
  • Earning Date
  • ACRV 11-07-2024
  • NWTN 01-01-0001
  • Dividend Yield
  • ACRV N/A
  • NWTN N/A
  • EPS Growth
  • ACRV N/A
  • NWTN N/A
  • EPS
  • ACRV N/A
  • NWTN N/A
  • Revenue
  • ACRV N/A
  • NWTN $583,000.00
  • Revenue This Year
  • ACRV N/A
  • NWTN N/A
  • Revenue Next Year
  • ACRV N/A
  • NWTN N/A
  • P/E Ratio
  • ACRV N/A
  • NWTN N/A
  • Revenue Growth
  • ACRV N/A
  • NWTN N/A
  • 52 Week Low
  • ACRV $3.19
  • NWTN $0.59
  • 52 Week High
  • ACRV $11.90
  • NWTN $9.88
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 57.76
  • NWTN 36.61
  • Support Level
  • ACRV $6.87
  • NWTN $0.62
  • Resistance Level
  • ACRV $8.16
  • NWTN $0.72
  • Average True Range (ATR)
  • ACRV 0.33
  • NWTN 0.06
  • MACD
  • ACRV 0.13
  • NWTN 0.01
  • Stochastic Oscillator
  • ACRV 77.86
  • NWTN 0.62

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About NWTN NWTN Inc.

NWTN Inc is a pioneering smart electric vehicle company which aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology into a passenger-centric green premium mobility solution to the world.

Share on Social Networks: